moleculefinder

Tadalafil

C22H19N3O4389.4 g/mol Calculated

Also called Cialis.

The PDE5 inhibitor sold as Cialis, used for erectile dysfunction, enlarged prostate and pulmonary hypertension. It lasts far longer than sildenafil.

Sources and notes
  • The introductionfrom sourceMoleculeFinder curated
  • Other namesfrom sourcePubChem / Wikidata
  • Formula and weightcomputedPubChem
  • 2D drawingcomputedPubChem structure, drawn by RDKit
  • 3D modelfrom sourcePubChem 3D conformerLoaded after the page has painted, and on a phone only when you ask for it; the 2D drawing shows until it arrives.

Where you encounter it

Dispensed on prescription, not sold on a shelf. Tadalafil on the product labels we hold.

Medicines

CialisAdded by the makerActive ingredient

Every product and list we hold

Sources and notes
  • The product labels and their strengthsfrom sourceDailyMed (FDA label)Each label lists the molecule as an ingredient, and an active ingredient at the strength shown.
  • How it gets therefrom sourceMoleculeFinder curatedEach mark is set by hand on our lists, never inferred; a label's ingredient is added by the maker. A row with no mark data says Not marked.
  • The line abovefrom sourceMoleculeFinder curatedFrom the group the molecule belongs to.

Explore its structure

Choose a part to light it up.

A C=O bonded to a nitrogen, the same link that joins amino acids in a protein. It is sturdy, and its nitrogen is not a base the way an amine's is.

From: standard chemistry.

Sources and notes
  • The drawingcomputedPubChem structure, drawn by RDKitThe page's one shipped drawing, with the chosen part lit in amber under it.
  • The partscomputedFound by ruleEach part is found by a chemical pattern, never picked by hand atom by atom; its words say where they come from.

Compare a related molecule

Sildenafil

Tadalafil

Sildenafil and tadalafil are both PDE5 inhibitors, but sildenafil acts for about four to six hours while tadalafil's effect can span a day and a half.

Sildenafil vs Tadalafil, side by side
Sources and notes
  • The sentencefrom sourceMoleculeFinder comparison notesThe pair's answer line.
  • The two drawingscomputedPubChem structures, drawn by RDKitThe two drawings side by side.

Properties and sources

Calculated by PubChem

Molecular formula
C22H19N3O4
Molecular weight
389.4 g/mol
XLogP3octanol/water, log units
2.3
Polar surface areatopological
74.9 Ų
H-bond donors
1
H-bond acceptors
4
Rotatable bonds
1
Complexity
702

Reported Hazard label (GHS), ECHA via PubChem

Warning Irritant pictogram (GHS07); hazard statements H302, H312, H315, H319, H332, H335

Reported Licence

The US Food and Drug Administration licenses Tadalafil for human use (NDA 021368, authorized November 21, 2003). Drugs@FDA

Groups it belongs to

Category
Prescription medicine
Chemical groups
Aromatics, Amides, Ethers
Elements
Nitrogen
Hazard classes
Irritant, GHS Warning
SMILESCN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36

PubChem CID 110635 · Wikidata Q424156 · InChIKey WOXKDUGGOYFFRN-IIBYNOLFSA-N · Data refreshed

How MoleculeFinder sources and labels its data

Questions
What is Tadalafil?
The PDE5 inhibitor sold as Cialis, used for erectile dysfunction, enlarged prostate and pulmonary hypertension. It lasts far longer than sildenafil.
How toxic is Tadalafil?
Its GHS hazard label carries the signal word Warning and the hazard pictogram Irritant. from source
What kind of molecule is Tadalafil?
Tadalafil has the formula C22H19N3O4 and a molecular weight of 389.4 g/mol. MoleculeFinder files it under PDE5 inhibitor, in the prescription medicine group. from sourcefrom sourcefrom sourcefrom source
Who licenses Tadalafil as a medicine?
The US Food and Drug Administration licenses Tadalafil for human use (NDA 021368, authorized November 21, 2003). from source
Sources and notes
  • Calculated valuescomputedPubChemComputed from the structure, so no laboratory conditions apply; complexity is PubChem's own structural score.
  • Hazard labelfrom sourceECHA via PubChemThe label combines these classifications.
  • ECHAfrom sourceAttributionSource: European Chemicals Agency, echa.europa.eu.
  • Licencefrom sourceDrugs@FDARead 2026-10-21.
  • Data refreshedfrom sourceMoleculeFinder2026-11-09

Keep exploring

Sources and notes
  • Compared side by sidefrom sourceMoleculeFinder comparison notesA molecule we compare it with on its own page.
  • The drawingscomputedPubChem structures, drawn by RDKit